发明名称 |
Anti-malarial agents |
摘要 |
The present invention is related to a use of aminopyrazine derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to aminopyrazine derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation. In one embodiment, the invention provides aminopyrazine derivatives having the following formula:; |
申请公布号 |
US9266842(B2) |
申请公布日期 |
2016.02.23 |
申请号 |
US201314379332 |
申请日期 |
2013.02.15 |
申请人 |
MMV MEDICINES FOR MALARIA VENTURE;UNIVERSITY OF CAPE TOWN |
发明人 |
Younis Yassir;Chibale Kelly;Witty Michael John;Waterson David |
分类号 |
A61K31/497;A61K31/4965;C07D241/20;C07D401/04;C07D401/14;C07D403/10;C07D401/10;A61K31/551;A61K31/5377;A61K45/06 |
主分类号 |
A61K31/497 |
代理机构 |
Saliwanchik, Lloyd & Eisenschenk |
代理人 |
Saliwanchik, Lloyd & Eisenschenk |
主权项 |
1. An aminopyrazine according to Formula (I), wherein X is CR1 or N; Y is selected from CF3, —C(O)—NR3R4; O—R6; SO2R6; R1 is selected from H and halogen; R2 is selected from SO2—R5 and —C(O)—R10; R3 and R4 are independently selected from H and optionally substituted C1-C6 alkyl; R5 is selected from —NR7R8 and R9; R6 is optionally substituted C1-C6 alkyl; R7 and R8 are independently selected from H and optionally substituted C1-C6 alkyl; R9 is an optionally substituted C1-C6 alkyl; R10 is —NR11R12; R11 and R12 are independently selected from H and optionally substituted C1-C6 alkyl or NR11R12 form together an optionally substituted heterocycloalkyl; or a pharmaceutically acceptable salt, hydrate, solvate, or polymorph, tautomer, geometrical isomer, or an optically active form thereof. |
地址 |
Geneva CH |